Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-09 Bright Rex Director Grant or award · Stock Options +12,773 12,773
2020-03-09 Bright Rex Director Grant or award · Stock Options +14,778 14,778
2020-03-09 Bright Rex Director Grant or award · Stock Options +29,271 29,271
2020-03-09 Bright Rex Director Grant or award · Stock Options +22,603 22,603
2020-03-09 Basta Steven L Director Grant or award +7,108 522,038
2020-03-09 BARBARI SHARON SURREY Director Grant or award · Stock Options +29,271 29,271
2019-12-11 BALL KRISTINE M Exercise or conversion +80,300 80,300
2019-12-11 BALL KRISTINE M Shares withheld for taxes −27,766 $4.52 $126K 52,534
2019-12-11 BALL KRISTINE M Exercise or conversion · Restricted Stock Units −80,300 0
2019-12-11 Kwon Paul Chief Scientific Officer Exercise or conversion +80,300 80,300
2019-12-11 Kwon Paul Chief Scientific Officer Shares withheld for taxes −27,766 $4.52 $126K 52,534
2019-12-11 Kwon Paul Chief Scientific Officer Exercise or conversion · Restricted Stock Units −80,300 0
2019-12-11 Basta Steven L Chief Executive Officer Exercise or conversion +238,800 580,974
2019-12-11 Basta Steven L Chief Executive Officer Shares withheld for taxes −85,210 $4.52 $385K 495,764
2019-12-11 Basta Steven L Chief Executive Officer Exercise or conversion +14,000 $1.83 $26K 509,764
2019-12-11 Basta Steven L Chief Executive Officer Exercise or conversion · Restricted Stock Units −238,800 0
2019-12-11 Basta Steven L Chief Executive Officer Exercise or conversion · Non-Qualified Stock Option −14,000 $1.83 $26K 357,641
2019-12-11 Kwon Paul Chief Scientific Officer Exercise or conversion +80,300 80,300
2019-12-11 Kwon Paul Chief Scientific Officer Shares withheld for taxes −27,766 $4.52 $126K 52,534
2019-12-11 Krasnow Ronald A. Exercise or conversion +24,090 24,090

Page 17 of 22 · 425 trades